Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation.
- 2023-03-23
- RCT · n = 78
- American journal of hematology 98(6)
- Yaqiong Tang
- Ziyan Zhang
- Silu Liu
- Yifang Yao
- Tingting Pan
- Jiaqian Qi
- Huizhu Kang
- Yuejun Liu
- Chengsen Cai
- Meng Zhou
- Xuefeng He
- Xiaohui Hu
- Xiao Ma
- Depei Wu
- Yue Han
- PubMed: 36880836
- DOI: 10.1002/ajh.26903
- High evidence
- Clinical
The estimated 3-year overall survival rate was 86.4% (±4.4%) and 79.9% (±4.7%) in 2 arms, respectively (p = .155).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- Not explicitly stated in abstract